Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array© using HPV52-specific TaqMan© E6/E7 quantitative real-time PCR

Journal of Virological Methods

Volumn 156, Issue 1-2, 2009, Pages 152-156

  Marks, Morgan ^a   Gupta, Swati B ^b   Liaw, Kai Li ^b   Kim, Esther ^a   Tadesse, Amha ^b   Coutlee, Francois ^c   Sriplienchan, Somchai ^d   Celentano, David D ^a   Gravitt, Patti E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NOTRE DAME HOSPITAL   (Canada)

^d Research Institute for Health Sciences   (Thailand)

Author keywords

Genotype; Human papillomavirus type 52; PCR; Taqman ; Thailand

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HYBRIDIZATION; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RURAL AREA; THAILAND; URBAN AREA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD;

CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THAILAND; VAGINAL SMEARS; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 52;

EID: 59949087132     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.10.013     Document Type: Article

References (18)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 4 (2002) 244-265
2. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.I., Bosch F.X., Munoz N., and Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 79 21 (2005) 13630-13640
3. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., Anh P.T., Ferreccio C., Hieu N.T., Matos E., Molano M., Rajkumar R., Ronco G., de Sanjose S., Shin H.R., Sukvirach S., Thomas J.O., Tunsakul S., Meijer C.J., and Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 9490 (2005) 991-998
4. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89 1 (2003) 101-105
5. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 1 (2003) 63-73
6. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., Voyer H., and Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40 3 (2002) 902-907
7. Coutlee F., Rouleau D., Ghattas G., Hankins C., Vezina S., Cote P., Macleod J., de Pokomandy A., Money D., Walmsley S., Voyer H., Brassard P., and Franco E. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J. Clin. Microbiol. 45 11 (2007) 3821-3823
8. Gravitt P.E., Peyton C.L., Apple R.J., and Wheeler C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 26 10 (1998) 3020-3027
9. Gravitt P.E., Kovacic M.B., Herrero R., Schiffman M., Bratti C., Hildesheim A., Morales J., Alfaro M., Sherman M.E., Wacholder S., Rodriguez A.C., and Burk R.D. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int. J. Cancer 121 12 (2007) 2787-2793
10. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., and Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38 1 (2000) 357-361
11. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., and Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35 3 (1997) 791-795
12. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., ter Harmsel B., and Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153 6 (1998) 1731-1739
13. Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52 5 (1992) 743-749
14. Sukvirach S., Smith J.S., Tunsakul S., Munoz N., Kesararat V., Opasatian O., Chichareon S., Kaenploy V., Ashley R., Meijer C.J., Snijders P.J., Coursaget P., Franceschi S., and Herrero R. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J. Infect. Dis. 187 8 (2003) 1246-1256
15. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., Kravang I., Torrez-Martinez N., Peyton C.L., and Wheeler C.M. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40 3 (2002) 979-983
16. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche Linear Array HPV genotyping test. J. Clin. Microbiol. 44 9 (2006) 3122-3129
17. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 1 (1999) 12-19
18. Yuan C.C., Miley W., and Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J. Virol. Methods 91 2 (2001) 109-117